These two examples illustrate that differences between records can be seen but that it is difficult to analyse them in detail. This was the reason for choosing to use punch tape records and subsequent computer analysis. We chose to use digital rather than analogue techniques because the latter are fairly inflexible and would have proved expensive. With the technique we are using it is possible, without having to repeat the recording, to measure various parameters at a later date by simply using the existing records and different programmes for the analysis. Fig 4 is an example of the type of computer analysis obtainable. By plotting the root mean square of velocity against the root mean square of position for the 200 second test period it can be seen that the majority of cases cluster together, but that a few cases are separated and appear in the top right hand quadrant of the graph. All these are from people with recognizable disorders and include the case with Meniere's disease mentioned above. However, it is not possible by this method to make a precise distinction between the normal and the abnormal. The swollen brain is still a troublesome problem for the neurological surgeon. When the dura is opened the brain may bulge in a frightening manner or alternatively the brain tissue may rupture. A less dramatic but no less important problem is raised intracranial pressure limiting access to deeply placed lesions, leading to brain bruising or abandonment of certain -operations. In recent years the volatile anesthetic agents halothane, Trilene and methoxyflurane have been shown to produce significant increases in CSF pressure, in the absence of associated changes-in either central venous pressure or carbon dioxide tension. The increase in CSF pressure produced by these agents has been shown to be greatly augmented in patients with intracranial spaceoccupying lesions (Fitch et al. 1969) .
Many techniques and agents have been used in efforts to reduce intracranial pressure and thereby provide better operating conditions, or a safety margin during investigations such as cerebral angiography or ventriculography. Most interest has centred on the intravenous hypertonic solutions, the osmotherapeutic agents. These all have limitations; some are less efficient than others and one at least, urea, is in our view contraindicated on account of the local tissue damage which may result from leakage of the intravenous infusion. Also, it is important that the infusion of osmotherapeutic agents is accompanied by knowledge of the effects on central venous pressure, blood pressure and intracranial pressure. This report details studies using the lwvorotary sugar fructose (molecular weight 180). Mannitol and the fructose-mannitol combination labelled Fructose-M have also been studied.
Patients undergoing craniotomy were premedicated with atropine and pethidine. Antsthesia was then induced with thiopentone. A cuffed endotracheal tube was inserted and controlled ventilation with a nitrous oxide-oxygen mixture maintained.
Ventilation was controlled with a Manley ventilator set at a minute volume to produce either normocapnia or hypocapnia, and this state was checked by blood sampling in the course of the operation. The central venous pressure catheter was inserted via a right anticubital vein and' slowly advanced to end in a great vein, this being confirmed by the appearance of respiratory fluctuations. The head was cleaned and draped for craniotomy and a frontal burr hole made. A metal Cairn's ventricular cannula was then inserted into the lateral ventricle via the burr hole and connected to a Statham type pressure transducer, a Devices amplifier and thence to a direct writing pen recorder.
Stability of the central venous pressure and of the intracranial pressure was assessed for several minutes and then the hypertonic fructose was administered. The solution used was 40 % in water at dosage of 20 ml/stone (3-15 ml/kg) body weight and the usual infusion volume was 200-240 ml. The infusion time was about 15 min. No further surgery was undertaken until the measurements of intracranial pressure were completed, as the turning of bone flaps could have influenced the intracranial pressure. Blood loss was minimal and would not have influenced the continuous central venous pressure measurements. Blood pressure was measured frequently by upper arm sphygmomanometer and pulse rate regularly recorded. Table 1 records changes in central venous pressure, systolic blood pressure and heart rate in 10 patients, following administration of 40% lwvulose. There was a significant increase in 11-9 ± 47 9 ± 10-7 ± 8-2 Hyperventilation -17-8 + 241-7 + 10 + 55
(PaCO, = 23-2 mmHg ± 1-2) 4-4 ± 6655 S :± 13-9 central venous pressure and systolic blood pressure, but the alteration in heart rate was not significant.
Further observations were made in two groups of patients, 6 in each group. In the first group normal ventilation techniques were employed with consequent low Pco2 figures. Intracranial pressure studies were also made in these cases. Table 2 details the results where the Pco2 value was in the normal range of 40 mmHg and here again there was a significant rise in central venous pressure. Blood pressure rose. There was a marked reduction in intracranial pressure. Table  3 details the hyperventilated group with Pco2 value about 23-2 mmHg. Here the central venous pressure rise was smaller. There was also a rise in blood pressure and a fall in intracranial pressure. Table 4 shows that the percentage rise in central venous pressure in the normoventilated group was 294-8% and in the hyperventilated group 241-7 %. The drop in intracranial pressure was 46-7 % in the normoventilated group compared with 17-8 % in the hyperventilated group.
The duration of effect of 40% lkvulose on central venous pressure at the different Pco2 levels is shown in change and the time to return to control are both longer in the normoventilated group than in the hyperventilated group.
These results indicate that intravenous administration of 40 % lavulose leads to: (1) A significant increase in central venous pressure. (2) A significant and useful reduction in intracranial pressure, commencing at 5 minutes and maximal at 20-25 minutes.
(3) A significant rise in blood pressure, which may account for the increased bleeding in the superficial tissues sometimes encountered at operation. (4) A variable effect on heart rate. It would appear that the addition of hyperventilation techniques adds little to the effect of lhvulose with respect to intracranial pressure reduction, or alternatively that levulose adds little to the effect of hyperventilation. On the other hand the rises in central venous pressure and blood pressure are less under hyperventilation techniques and in certain cases this could be important.
Those using this osmotherapeutic agent should be aware of the central venous pressure changes, particularly in patients with cardiothoracic disease, or if the central venous pressure is used for determining blood volume or loss. Readings may be misleading unless the changes described and the time-span during which they are operative are borne in mind. This reservation would apply to blood pressure recordings which may in some circumstances be misleadingly high. REFERENCE Fitch W, Barker J, McDowall D G & Jennett W B (1969) Brit. J. Anasth. 41, 564 
